Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling

Circulation. 2012 Jul 10;126(2):196-206. doi: 10.1161/CIRCULATIONAHA.111.039644. Epub 2012 Jun 5.


Background: Heart failure is associated with neurological deficits, including cognitive dysfunction. However, the molecular mechanisms underlying reduced cerebral blood flow in the early stages of heart failure, particularly when blood pressure is minimally affected, are not known.

Methods and results: Using a myocardial infarction model in mice, we demonstrate a tumor necrosis factor-α (TNFα)-dependent enhancement of posterior cerebral artery tone that reduces cerebral blood flow before any overt changes in brain structure and function. TNFα expression is increased in mouse posterior cerebral artery smooth muscle cells at 6 weeks after myocardial infarction. Coordinately, isolated posterior cerebral arteries display augmented myogenic tone, which can be fully reversed in vitro by the competitive TNFα antagonist etanercept. TNFα mediates its effect via a sphingosine-1-phosphate (S1P)-dependent mechanism, requiring sphingosine kinase 1 and the S1P(2) receptor. In vivo, sphingosine kinase 1 deletion prevents and etanercept (2-week treatment initiated 6 weeks after myocardial infarction) reverses the reduction of cerebral blood flow, without improving cardiac function.

Conclusions: Cerebral artery vasoconstriction and decreased cerebral blood flow occur early in an animal model of heart failure; these perturbations are reversed by interrupting TNFα/S1P signaling. This signaling pathway may represent a potential therapeutic target to improve cognitive function in heart failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebral Arteries / pathology
  • Cerebral Arteries / physiopathology*
  • Etanercept
  • Heart Failure / physiopathology*
  • Immunoglobulin G / pharmacology
  • Lysophospholipids / physiology*
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Models, Animal
  • Muscle Development / physiology*
  • Muscle, Smooth, Vascular / physiopathology*
  • Phosphotransferases (Alcohol Group Acceptor) / deficiency
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Phosphotransferases (Alcohol Group Acceptor) / physiology
  • Receptors, Lysosphingolipid / deficiency
  • Receptors, Lysosphingolipid / genetics
  • Receptors, Lysosphingolipid / physiology
  • Receptors, Tumor Necrosis Factor
  • Regional Blood Flow / drug effects
  • Regional Blood Flow / physiology
  • Signal Transduction / physiology*
  • Sphingosine / analogs & derivatives*
  • Sphingosine / physiology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / physiology*
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology


  • Immunoglobulin G
  • Lysophospholipids
  • Receptors, Lysosphingolipid
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • sphingosine 1-phosphate
  • Phosphotransferases (Alcohol Group Acceptor)
  • sphingosine kinase
  • Sphingosine
  • Etanercept